Search Results - Singson, Victoria

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Abstract 3202: A probody drug conjugate targeting CD166 (ALCAM) enhances preclinical antitumor activity of a probody therapeutic targeting PD-1

    Abstract 3202: A probody drug conjugate targeting CD166 (ALCAM) enhances preclinical antitumor activity of a probody therapeutic targeting PD-1 by Scolan, Erwan Le, Tse, Tiffany, Krimm, Michael, Garner, Will, Assi, Hikmat, Razo, Jennifer, Wong, Laurie, Wong, Kenneth, Singson, Victoria, Leong, Jennifer, Diep, Linnea, Richardson, Jennifer, Schleyer, Siew, Daniel, Dylan, Belvin, Marcia, Kavanaugh, Michael

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents

    Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents by Assi, Hikmat H, Wong, Chihunt, Tipton, Kimberly A, Mei, Li, Wong, Ken, Razo, Jennifer, Chan, Chanty, Howng, Bruce, Sagert, Jason, Krimm, Michael, Diep, Linnea, Jang, Andrew, Nguyen, Margaret T, Lapuyade, Nicole, Singson, Victoria, Villanueva, Ruth, Paidhungat, Madan, Liu, Shouchun, Rangan, Vangipuram, Vasiljeva, Olga, West, James W, Richardson, Jennifer H, Irving, Bryan, Daniel, Dylan, Belvin, Marcia, Kavanaugh, W Michael

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    367 CRISPR/Cas9 gene-edited, allogeneic anti-CD83 CAR-T cells demonstrate potent activity in GvHD and AML tumor models

    367 CRISPR/Cas9 gene-edited, allogeneic anti-CD83 CAR-T cells demonstrate potent activity in GvHD and AML tumor models by Oumzil, Ismael, Guerrero, Valerie, Keerthipati, Pooja Smruthi, Colangelo, Jaqlyn, Lawler, Brendan, Singson, Victoria, Khedkar, Aditya, Singh, Shweta, Terrett, Jonathan, Hostetter, Daniel

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 3211: PD-1-targeted Probody therapeutics provide anti-tumor efficacy and a 10-fold dose protection against systemic autoimmunity in preclinical studies

    Abstract 3211: PD-1-targeted Probody therapeutics provide anti-tumor efficacy and a 10-fold dose protection against systemic autoimmunity in preclinical studies by Tipton, Kimberly A., Chan, Chanty, Wong, Kenneth R., Singson, Victoria, Richardson, Jennifer H., Kavanaugh, W Michael, Irving, Bryan A., West, James W.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: